Dietary ε-Polylysine Affects on Gut Microbiota and Plasma Metabolites Profiling in Mice

Abstract

Given the antibacterial effects of ε-polylysine acting on cell membranes, and that glycerol phospholipids are important components of the cell membrane, we hypothesized that ε-polylysine may regulate glycerophospholipid metabolism by modifying the gut microbiota. To test this hypothesis, we treated post-weaning C57 mice with different levels of ε-polylysine (0, 300, 600, and 1,200 ppm) in their basic diet. The growth performance and morphology of intestine were then determined. Modification of the gut microbiota and their function were analyzed using 16S rDNA sequencing. Metabolite identification was performed using the LC-MS method. The results showed that body weight decreased with an increasing supplemental level of ε-polylysine from 5 to 7 weeks (P < 0.05), but no significant difference was observed after 8 weeks (P > 0.05). Supplementation with 1,200 ppm ε-polylysine changed the morphology of the jejunum and ileum, increased the villus length, decreased the crypt depth of the jejunum, and decreased the villus length and crypt depth of the ileum (P < 0.05). ε-Polylysine shifted the intestine microbiota by changing alpha diversity (Chao 1, observed species, Shannon, and Simpson indices) and varied at different times. ε-polylysine decreased Firmicutes and increased Bacteroidetes at 4 week, but increased Firmicutes and decreased Bacteroidetes at 10 week. ε-Polylysine regulated genera associated with lipid metabolism such as Parabacteroides, Odoribacter, Akkermansia, Alistipes, Lachnospiraceae UCG-001, Collinsella, Ruminococcaceae, and Intestinimonas. During the adult period, the genera Alistipes, Lachnospiraceae UCG-001, and Streptomyces were positively associated with PC, PE, LysoPC, LysoPE, 1-Arachidonoylglycerophosphoinositol and OHOHA-PS (R > 0.6, P < 0.001), but changes in Blautia, Christensenellaceae R-7 group, Odoribacter, Allobaculum, Ruminococcaceae UCG-004, Ruminococcaceae UCG-005, and Lachnospiraceae UCG-010 were negatively correlated with glycerophospholipid metabolites (R < −0.6, P < 0.001). The abundance of glycerophospholipid metabolites, including PC, PE, lysoPC, and lysoPE, were decreased by ε-polylysine. Furthermore, ε-polylysine reduced the incidence of the genera including Ruminococcus, Prevotella, Prevotellaceae, Butyricimonas, and Escherichia-Shigella and reduced the abundance of Faecalibaculum, Christensenellaceae R-7 group, Coriobacteriaceae UCG-002. In conclusion, ε-polylysine modified gut microbiota composition and function while also restraining pathogenic bacteria. The glycerophospholipid metabolism pathway and associated metabolites may be regulated by intestinal bacteria.

The Effect of Broccoli Glucoraphanin Supplementation on Ameliorating High‐Fat‐Diet‐Induced Obesity through the Gut Microbiome and Metabolome Interface

“…[107] Importantly, GRN increased the abundance of Lachnoclostridium, Ruminococcaceae, Enterorhadus, and Mucispirillum that are associated with metabolic protective effects but negatively correlated with glycerolipid and glycerophospholipid metabolites such as LPC and certain ceramides that are associated with obesity and inflammation. [108][109][110] Further correlation analyses demonstrated that GRN-induced microbial and metabolite changes were positively associated with reduced body weight and body fat accumulation as well as improved glucose metabolism. Therefore, the interplay between the gut microbial composition and metabolomics profiles caused by GRN supplementation may provide a potential mechanistic insight for GRN-induced obesity prevention.…”

The role of gut microbiota and blood metabolites in postpartum depression: a Mendelian randomization analysis

“…Our research also identified a novel association between Bifidobacterium and elevated levels of LysoPI, a lysophosphatidylinositol potentially implicated in immune and inflammatory responses, as suggested by its links to conditions like asthma, COVID-19, and cervical inflammation in existing literature ( Zhang et al., 2018 ; Gu et al., 2022 ; Tu et al., 2024 ). Furthermore, the relevance of phospholipid metabolism, particularly LysoPI, in PPD pathophysiology, underscores the potential of dietary interventions, such as ϵ-polylysine supplementation, to influence gut microbiota and blood metabolite profiles, offering promising avenues for PPD prevention and treatment ( Zhang et al., 2022 ).…”

Gut–brain communication mediates the impact of dietary lipids on cognitive capacity

“…Phospholipids are key components of all cellular and subcellular membranes and essential for membrane function and integrity. 153,154 Moreover, phospholipids, as conduction signaling of intestinal inflammatory factors, participate in the maintenance of metabolic and immune homeostasis and the inhibition of the inflammatory response, 155 and the pathogenesis of type 2 diabetes, 156 fatty liver disease and schizophrenia-related behaviors. 157,158 Phospholipids are divided into phosphoglycerides and sphingomyelin (SM).…”